0000000000886840

AUTHOR

Ibane Abasolo

0000-0001-5970-6276

showing 2 related works from this author

Alteration of the Mitochondrial Effects of Ceria Nanoparticles by Gold: An Approach for the Mitochondrial Modulation of Cells Based on Nanomedicine

2020

Ceria nanoparticles are cell compatible antioxidants whose activity can be enhanced by gold deposition and by surface functionalization with positive triphenylphosphonium units to selectively target the mitochondria. The antioxidant properties of these nanoparticles can serve as the basis of a new strategy for the treatment of several disorders exhibiting oxidative stress, such as cancer, diabetes or Alzheimer&rsquo

AntioxidantantioxidantGeneral Chemical Engineeringmedicine.medical_treatmentNanoparticleceria nanoparticles02 engineering and technologyMitochondrionmedicine.disease_causeArticlelcsh:Chemistry03 medical and health scienceschemistry.chemical_compoundQUIMICA ORGANICAmitochondrial functionmedicineGeneral Materials ScienceNRF1Gold-supported ceria nanoparticles030304 developmental biology0303 health sciencesChemistryfungigold-supported ceria nanoparticlesfood and beveragestriphenylphosphonium gold-supported ceria nanoparticles021001 nanoscience & nanotechnologylcsh:QD1-999Colloidal goldBiophysicsNanomedicineMitochondrial functionAntioxidant0210 nano-technologyAdenosine triphosphateCeria nanoparticlesOxidative stressTriphenylphosphonium gold-supported ceria nanoparticles
researchProduct

Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories : production of human alpha-gala…

2015

This work was supported by ERANET-IB08-007 project from the European Union and its linked national project EUI2008- 03610 to AV. We also appreciate the support from EME2007-08 to NFM from Universitat Autonoma de Barcelona, from Antartide 2010 to MLT and EP, from MIUR Azioni Integrate Italia-Spagna 2010 Prot. IT10LECLM9 to MLT, from MINECO (IT2009-0021) to AV and LT, from AGAUR (2009SGR-108) to AV. AV is also supported by The Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN, Spain), an initiative funded by the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Car…

PseudoalteromonaRecombinant proteinExpression systemsFabry's diseaseHuman alpha-galactosidase AContext (language use)Computational biologyBiologymedicine.disease_causeApplied Microbiology and BiotechnologyMicrobiologyPseudoalteromonas haloplanktisGene expressionEnzyme StabilitymedicineProtein biosynthesisEscherichia coliHumansEscherichia coliGenePseudoalteromonas haloplanktis TAC125Expression systemGeneral Medicinebiology.organism_classificationRecombinant ProteinsPseudoalteromonasMembrane proteinFabry’s diseaseMetabolic Engineeringalpha-GalactosidaseProtein foldingBiotechnologyHuman
researchProduct